| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972917 | The Journal of Heart and Lung Transplantation | 2007 | 9 Pages |
Abstract
Iloprost and bosentan allowed the effective bridge-to-transplant treatment in IPAH. However, with this treatment the mortality rate on Tx lists remained high and survival benefit was lower than from transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael MD, PhD, Hans B. MD, Sead MD, Yuguo MD, PhD, Dagmar MD, Onnen MD, PhD, Christoph MD, PhD, Roland MD, PhD,